7 research outputs found
Tissue-specific mtDNA abundance from exome data and its correlation with mitochondrial transcription, mass and respiratory activity.
Eukaryotic cells contain a population of mitochondria, variable in number and shape, which in turn contain multiple copies of a tiny compact genome (mtDNA) whose expression and function is strictly coordinated with the nuclear one. mtDNA copy number varies between different cell or tissues types, both in response to overall metabolic and bioenergetics demands and as a consequence or cause of specific pathological conditions. Here we present a novel and reliable methodology to assess the effective mtDNA copy number per diploid genome by investigating off-target reads obtained by whole-exome sequencing (WES) experiments. We also investigate whether and how mtDNA copy number correlates with mitochondrial mass, respiratory activity and expression levels. Analyzing six different tissues from three age- and sex-matched human individuals, we found a highly significant linear correlation between mtDNA copy number estimated by qPCR and the frequency of mtDNA off target WES reads. Furthermore, mtDNA copy number showed highly significant correlation with mitochondrial gene expression levels as measured by RNA-Seq as well as with mitochondrial mass and respiratory activity. Our methodology makes thus feasible, at a large scale, the investigation of mtDNA copy number in diverse cell-types, tissues and pathological conditions or in response to specific treatments.This work was supported by Ministero dell'Istruzione, UniversitĂ e Ricerca (projects PRIN-2009, Micromap [PON01_02589], Virtualab [PON01_01297]) and by Consiglio Nazionale delle Ricerche (progetto strategico âMedicina personalizzataâ, progetto strategico âInvecchiamentoâ, progetto bandiera âEpigenâ)
Association of functional genetic variation in PP2A with prefrontal working memory processing
Variation in prefrontal dopaminergic signaling mediated by D2 receptor has been implicated in cognitive
phenotypes of schizophrenia, including working memory. Molecular cascades downstream of D2 receptor
include a cAMP-dependent- and a cAMP-independent-pathway. Protein-Phosphatase-2A (PP2A) is a key
partner of D2 receptor in cAMP-independent signaling. This enzyme comprises a regulatory subunit
that is coded by PPP2R2B gene. Given the molecular relationship between PP2A and D2 signaling, we
hypothesized genetic variation in PPP2R2B affecting mRNA expression of this gene in prefrontal cortex to
be associated with prefrontal processing during working memory. In order to probe such a hypothesis we
investigated SNPs associated with PPP2R2B expression in two independent samples of human postmortem
prefrontal cortex. Then, we tested SNPs for which association was replicated as predictors of prefrontal
activity during WM as probed by functional magnetic resonance (fMRI) in a sample of healthy humans. We
found that a SNP associated with PPP2R2B expression (rs959627) predicted prefrontal activity during the
N-Back working memory task. In particular, individuals carrying rs959627T allele, a condition associated
with lower PPP2R2B expression in postmortem prefrontal cortex, showed greater activity in right inferior
frontal gyrus (IFG) during N-Back compared to CC subjects. Furthermore, such an activity was negatively
correlated with behavioral performance at the task.
Consistently with previous studies, these findings suggest reduced right IFG efficiency during working
memory processing in rs959627 T-carriers, as indexed by their greater need to activate this brain region
in order to achieve similar levels of behavioral proficiency as compared to CC individuals
Respiratory function in a large cohort of treatment-naĂŻve adult spinal muscular atrophy patients: a cross-sectional study
: Due to poor data in literature, we aimed to investigate the respiratory function in a large cohort of naĂŻve Italian adult (â„18 years) SMA patients in a multi-centric cross-sectional study. The following respiratory parameters were considered: forced vital capacity (FVC), forced expiratory volume in one second (FEV1) and need for non-invasive ventilation (NIV). We included 145 treatment-naĂŻve adult patients (SMA2=18, SMA3=125; SMA4=2), 58 females (40 %), with median age at evaluation of 37 years (range 18-72). Fifty-six (37 %) and 41 (31 %) patients had abnormal (<80 %) values of FVC and FEV1, respectively. Fourteen (14 %) patients needed NIV, started at median age of 21 (range 4-68). Motor function, measured by Hammersmith Functional Motor Scale Expanded and Revised Upper Limb Module as well as SMA2, loss of walking ability, surgery for scoliosis, use of NIV, and cough assisting device (CAD) were all significantly associated to lower FVC and FEV1 values, while no association with age at baseline, disease duration, gender or 6 min walking test was observed, except for a correlation between FVC and age in SMA3 walkers (p < 0.05). In conclusion, respiratory function in adult SMA patients is relatively frequently impaired, substantially stable, and significantly correlated with motor function and disease severity
Adults with spinal muscular atrophy: a large-scale natural history study shows gender effect on disease
Natural history of spinal muscular atrophy (SMA) in adult age has not been fully elucidated yet, including factors predicting disease progression and response to treatments. Aim of this retrospective, cross-sectional study, is to investigate motor function across different ages, disease patterns and gender in adult SMA untreated patients
Digital health and Clinical Patient Management System (CPMS) platform utility for data sharing of neuromuscular patients: the Italian EURO-NMD experience
Abstract Background The development of e-health technologies for teleconsultation and exchange of knowledge is one of the core purposes of European Reference Networks (ERNs), including the ERN EURO-NMD for rare neuromuscular diseases. Within ERNs, the Clinical Patient Management System (CPMS) is a web-based platform that seeks to boost active collaboration within and across the network, implementing data sharing. Through CPMS, it is possible to both discuss patient cases and to make patientsâ data available for registries and databases in a secure way. In this view, CPMS may be considered a sort of a temporary storage for patientsâ data and an effective tool for data sharing; it facilitates specialistsâ consultation since rare diseases (RDs) require multidisciplinary skills, specific, and outstanding clinical experience. Following European Union (EU) recommendation, and to promote the use of CPMS platform among EURO-NMD members, a twelve-month pilot project was set up to train the 15 Italian Health Care Providers (HCPs). In this paper, we report the structure, methods, and results of the teaching course, showing that tailored, ERN-oriented, training can significantly enhance the profitable use of the CPMS. Results Throughout the training course, 45 professionals learned how to use the many features of the CPMS, eventually opening 98 panels of discussionâamounting to 82% of the total panels included in the EURO-NMD. Since clinical, genetic, diagnostic, and therapeutic data of patients can be securely stored within the platform, we also highlight the importance of this platform as an effective tool to discuss and share clinical cases, in order to ease both case solving and data storing. Conclusions In this paper, we discuss how similar course could help implementing the use of the platform, highlighting strengths and weaknesses of e-health for ERNs. The expected result is the creation of a âmapâ of neuromuscular patients across Europe that might be improved by a wider use of CPMS